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Introduction 
The pandemic of COVID-19 affected adults more 
severely compared to children who presented severe 
and even rare clinical manifestations, besides 
consequences defined as indirect and direct. The 
indirect effects consist of educational deficits, lack of 
socialization, mental health impairment leading to 
pathologies such as depression and anxiety, increased 
violence, decreased vaccination coverage, increased 
hunger, it is also considered that these indirect effects 
of COVID-19 in children are greater than those caused 
by the direct form, such as clinical consequences and 
even death [1,2].  
Representative of the direct form are the 
manifestations that could be classified as Kawasaki 
syndrome and/or toxic shock syndrome [3]. Kawasaki 
disease (KD) is an acute primary systemic vasculitis that 
affects mainly medium-caliber vessels and is diagnosed 
primarily by clinical analysis. In severe cases, KD 
manifests as toxic shock syndrome, which may or may 
not be followed by multiple organ dysfunction syndrome 
[4,5]. 
Thus, the worsening of this condition may define 
the syndrome was called Multisystem inflammatory 
syndrome in children (MIS-C), which has incidence in 
children between 5 and 17 years of age, with or without 
previous cardiac involvement and positive for SARS-Cov-
2 virus with severe disease. Then, besides the 
gastrointestinal involvement, there are also skin lesions 
that are probably derived from long-lasting fever, non-
productive conjunctivitis, and neuropathic symptoms, 
and also, there is a severe cardiovascular tissue lesion, 
where it can evolve with compromising of the arterial 
and vascular walls, especially the coronary ones, due to 
its close connection with the infected myocardium. 
Thus, this study aimed to analyze the relationship 
between Kawasaki disease and COVID-19 for the 
development of MIS-C. 
 
Methods 
This is a systematic literature review based on the 
following scientific questions: 1 - Is there a relationship 
between the manifestation of Kawasaki Disease and 
COVID-19? 2 - If there is such a relationship, can 
another condition arise? 3 - What are the manifestations 
of MIS-C? Are there other consequences? The articles 
selected for the study had to meet the following 
eligibility criteria: (1) be published in a national and 
international journal; (2) in the period from 2020 to 
2021; (3) and be freely available in full. Articles that did 
not answer the scientific questions proposed by the 
study were excluded.  
A literature search was conducted in the electronic 
databases BVS/LILACS, Scielo, and PubMed in the 
period from 2020 to 2021. The search strategy included 
the following descriptors: "Kawasaki Disease OR 
Kawasaki Syndrome", "MIS-C" and ''COVID-19''.  In a 
first step to select the studies, duplicates were removed 
and the research team screened the titles. Next, 
abstracts of eligible studies were selected to perform 
full-text screening. The selected articles underwent peer 
review, and disagreements between reviewers were 
reviewed by the study advisor. 
After full-text screening, research team members 
extracted data from the included studies using a data 
extraction form, which included information on study 
characteristics (title, year and country of publication), 
methods (study design), and scientific questions were 
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Results and Discussion 
A total of 606 articles were found, n = 499 from 
the PubMed platform, n = 77 from Scielo, and n=30 
from Lilacs. Of the articles that met the inclusion criteria, 
n = 34 were found in total, of these only n=9 were from 
Scielo, n = 4 from Lilacs, and n = 21 from PubMed.  
Children manifest a high inflammatory response that 
possibly causes cardiac lesions and develops Kawasaki 
disease more rapidly. Consequently, these different 
presentations when compared to adults, cause 
complications in some devices, such as cardiovascular, 
the main one being early myocarditis in 56% of patients, 
evolving with hemodynamic instability and developing 
Kawasaki Disease Shock Syndrome (KDSS). KDSS can 
affect up to 7 out of 10 patients with Kawasaki Disease, 
but when associated with COVID-19, this complication 
reaches 52% [5-17]. 
Among the first series of cases containing 
multisystemic inflammatory syndrome, eight patients in 
the age range of 4 to 17 years were reported [4]. Thus, 
all of them evolved to cardiogenic shock and one of the 
patients to coronaritis, which is characteristic of 
Kawasaki syndrome. There was a pediatric case of DK 
and COVID-19 concurrently published in April 2020. 
After that, similar cases to this one were published in 
European and American countries about multisystemic 
inflammatory syndrome, in which it has many clinical 
and laboratory aspects similar to DK [5-10], but differ in 
the rates of cardiac involvement, age range, and 
predominance of African descendant ethnicity [4,11-
14]. 
The cases in question occurred a few days after the 
manifestation of COVID-19 in the patients. MIS-C has a 
lower frequency of respiratory symptoms consequent to 
hemodynamic decompensation [16,17]. However, there 
are three inheritance patterns in cases of children 
hospitalized with MIS-C, these being: shock or organ 
failure, persistent fever, but without features of 
Kawasaki Disease; second pattern that characterizes the 
diagnosis of DK; and the third pattern that is severe 
containing cardiac, gastrointestinal, and systemic 
dysfunction [18]. The serological test with detection of 
anti-IgG [16] antibodies is used to confirm the diagnosis 
of active viral infection in patients with Kawasaki 
Disease, and was applied to 44 children participating in 
this study, showing a reactive result in 91% of cases 
[19-27]. 
It is notable that this inflammatory cardiovascular 
condition occurs mainly in pediatrics in 50% of all 
reported cases in children under 2 years of age, and 
80% of the other cases that are concentrated in ages 2 
to 5 years. The association between severe respiratory 
viral infection corresponds between 9% and 42% of 
children with Kawasaki vasculitis who were positive for 
this severe respiratory infection with 30 days before 




There is a relationship between the damage at the 
cellular level by the virus and the severe vascular 
inflammatory condition, but it is noticeable that the 
cases do not present patterns of occurrence, except for 
a symptomatology extremely similar to Kawasaki 
Syndrome, without the need for previous cardiac 
involvement. Therefore, MIS-C is responsible for the 
cardiac damage caused by SARS-CoV-2. Therefore, it is 
extremely important to differentiate the presentation of 
each of these pathologies, so that early and appropriate 
management can occur. 
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